Cancer Hospital of Chinese Academy of Medical Sciences

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

Each strip is that field’s whole ranked pool, with the notch where Cancer Hospital of Chinese Academy of Medical Sciences sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

1. Medicine#7,819 #4,014
2. Health Sciences#9,834 #4,928
3. Life Sciences#7,480 #3,648
4. Biochemistry, Genetics and Molecular Biology#6,043 #2,745

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Where its research is concentrated relative to its size: Oncology takes 13.3× the share of its output that it takes of world research.

1. OncologySubfield · 39.6 works13×
2. Pulmonary and Respiratory MedicineSubfield · 32.7 works8.1×
3. Molecular BiologySubfield · 39.0 works4.9×
4. Biochemistry, Genetics and Molecular BiologyField · 62.3 works4.4×

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Biochemistry, Genetics and Molecular Biology 4.4×
• Immunology and Microbiology 3.1×
• Medicine 3.0×
• Pharmacology, Toxicology and Pharmaceutics 1.2×
• Chemistry 1.1×
• Neuroscience 0.8×
• Materials Science 0.6×
• Nursing 0.6×
• Dentistry 0.4×
• Physics and Astronomy 0.3×
• Energy 0.3×
• Engineering 0.2×
• Health Professions 0.2×
• Computer Science 0.2×
• Environmental Science 0.1×
• Psychology 0.1×
• Agricultural and Biological Sciences 0.1×
• Economics, Econometrics and Finance 0.1×
• Arts and Humanities 0.1×
• Decision Sciences 0.1×
• Chemical Engineering 0.0×
• Mathematics 0.0×
• Social Sciences 0.0×

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Cancer, Tumor Microenvironment, Immunotherapy, Metastasis, Clinical Trials, Targeted Therapy and Clinical Practice Guidelines.

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Ferroptosis and cancer prognosis and Gastric Cancer Management and Outcomes.

1. 1 Cancer Immunotherapy and Biomarkers Oncology 8 works
2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
3. 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
4. 4 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 6 works
5. 5 Lung Cancer Research Studies Oncology 6 works
6. 6 Advanced biosensing and bioanalysis techniques Molecular Biology 5 works
7. 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
8. 8 Esophageal Cancer Research and Treatment Surgery 4 works
9. 9 Head and Neck Cancer Studies Otorhinolaryngology 4 works
10. 10 Cancer-related molecular mechanisms research Cancer Research 3 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 362% higher than in 2013–2017.

• Chinese Academy of Sciences
• Tsinghua University
• Peking University
• University of Chinese Academy of Sciences
• Beihang University
• Beijing Institute of Technology
• Chinese Academy of Medical Sciences & Peking Union Medical College
• North China Electric Power University